Filing Flows

Filing Flows › Varex Imaging (VREX) › Q3 FY26

Varex Imaging (VREX) Q3 FY26 earnings results (third quarter fiscal 2026)

10-Q filed Aug 10, 2026

Varex Imaging (VREX) reported revenue of $210M for the third quarter fiscal 2026 (Q3 FY26), +4% from a year earlier and -3% from the quarter before. Operating margin was 10.8%, net earnings $15.9M (7.6% of revenue).

Revenue$210M
Year over year+4%
Quarter over quarter-3%
Operating margin10.8%
Net earnings$15.9M

Varex Imaging, Q3 FY26: revenue $210M (+4% year over year), operating margin 10.8%, net earnings $15.9M, operating cash flow $21.0M. The chart follows the revenue to costs, profit and cash.

Q3 FY26AmountQ/QY/Y
Revenue$210M-3%+4%
Gross profit$76.7M+6%+14%
Operating profit$22.8M+58%—
Net earnings$15.9M——
Operating cash flow$21.0M—+173%
Free cash flow$12.0M—+757%

What changed

Revenue was $210.5M in Q3 FY26, up 4% year over year and down 3% from the previous quarter. Medical was the largest line at 64% of revenue. Industrial added $15.6M year over year (up 26%), 208% of the total change. Medical declined 6%.

Gross margin was 36.4%, up 3.2 points from Q3 FY25. Operating profit was $22.8M, a 10.8% margin (up 50.6 points year over year). Operating expenses fell 64% while revenue rose 4%. Net earnings were $15.7M. The effective tax rate was 1.9%.

Operating cash flow was $21.0M (up 173% year over year), 132% of net earnings. Non-cash charges added back $7.0M of depreciation and amortization and $3.8M of share-based compensation. Working capital and other items used $5.7M. Capital expenditures of $9.0M left free cash flow of $12.0M.

Questions

What was Varex Imaging's revenue in the third quarter fiscal 2026?

Varex Imaging (VREX) reported revenue of $210M for the third quarter fiscal 2026 (Q3 FY26), +4% from a year earlier and -3% from the quarter before.

Was Varex Imaging profitable in the third quarter fiscal 2026?

Operating profit was $22.8M (10.8% of revenue) and net earnings $15.9M.

Open the interactive Sankey →

Source: Varex Imaging 10-Q on SEC EDGAR.